Anticancer Therapies – Multimedia

Download this infographic to learn more about the types of tumor heterogeneity, why heterogeneity can affect cancer treatment and how heterogeneity is linked to treatment resistance.

Download this listicle to learn more about immune checkpoint inhibitors and immune system modulators, adoptive cell therapies and oncolytic viral therapy.

This whitepaper explores the role of extracellular vesicles in cell-to-cell communication during cancer progression. It also highlights a range of high-quality recombinant proteins, antibodies and cytokines and to support exosome research.

Although there are initiatives to de-risk the drug development process, continually applying the same tools and approaches is unlikely to lead to innovative, first- or best-in-class targets and transformative progress.

According to the World Health Organization (WHO), cancer is a leading cause of death worldwide. Furthermore, recent estimates predict that as many as one in two people could develop a form of cancer in their lifetime.

This eBook explores how humanized mouse models can accelerate the development of novel, safe, and effective oncology treatment

Download this listicle to discover recent examples of how single-cell analysis methods are driving forward research into cancer, aging, and drug discovery and development.

Active cell therapy drugs represent the latest in cancer treatment. Of these, chimeric antigen receptor (CAR) cell modalities are considered the most successful.

CAR-T cell therapy has emerged as one of the most promising novel treatments in the fight against cancer.

The field of cancer immunology concerns the study of the interaction between the immune system and cancer cells.